SAGE Publishing provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.
LaTeX Template Conversion →01Impact factor
Impact factor of Journal of Drug Issues (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Journal of Drug Issues published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Substance Abuserank 43 of 59 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Journal of Drug Issues
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Journal of Drug Issues is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Article processing charge listed at about US$3,650.
Is your paper a fit for Journal of Drug Issues?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
Need a faster review? The fastest journals in Substance Abuse accept papers in a median of 66 days.
- Tobacco Induced Diseases 66 days
- Tobacco Prevention & Cessation 74 days
- Journal of Gambling Studies 92 days
APC waivers and discounts for Journal of Drug Issues APC about US$3,650
SAGE: automatic full waiver for Research4Life Group A and a discount for Group B, by the corresponding author's affiliation. Authors in 82 countries get a full waiver.
02Retractions
Retractions and research integrity at Journal of Drug Issues
Most common reasons (a retraction can have several):
Journal of Drug Issues has 1 retracted paper on record, the latest in Dec 2023. A retraction count is not a verdict on a journal: large journals publish more and journals that investigate actively retract more. The trend and the reasons tell you more than the number.
03Funders
Who funds research published in Journal of Drug Issues
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
04Indexing
Indexing of Journal of Drug Issues
- ISSN
- 0022-0426
- eISSN
- 1945-1369
- Publisher
- SAGE Publishing all its journals →
- Subjects
- Substance Abuse
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
05How to submit
How to submit to Journal of Drug Issues
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Journal of Drug Issues accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Use the journal's template. SAGE Publishing offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template.
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Journal of Drug Issues is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
06Reviewer comments
Reviewer comments and rejection reasons for Journal of Drug Issues
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Journal of Drug Issues, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Worried about the English? Manuscript editing by editors in your subject: see the price →
Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds07Same subject
Substance Abuse journals with a similar impact factor*
The journals next to Journal of Drug Issues when the 56 journals of Substance Abuse in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 39 | Alcohol | 1.19 | SCIE | Subscription |
| 40 | Substance Use Research and Treatment | 1.18 | ESCI | Subscription |
| 41 | Journal of Ethnicity in Substance Abuse | 1.12 | SCIE, SSCI | Subscription |
| 42 | Drug and Alcohol Dependence | 1.04 | SCIE, SSCI | Subscription |
| 44 | Journal of Addictions Nursing | 1.02 | SCIE, SSCI | Subscription |
| 45 | American Journal on Addictions | 1.02 | SSCI | Subscription |
| 46 | Heroin addiction and related clinical problems | 0.89 | SSCI | Subscription |
| 47 | Alcoholism Treatment Quarterly | 0.88 | ESCI | Subscription |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is Journal of Drug Issues right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 157,115 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
08Questions
Frequently asked questions
What is the impact factor of Journal of Drug Issues?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Journal of Drug Issues is 1.03: papers it published in the two previous years were cited 1.03 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Journal of Drug Issues?
The h-index of Journal of Drug Issues is 87 (October 2026): 87 of its papers have each been cited at least 87 times. Its i10-index is 1,188.
What is the APC of Journal of Drug Issues?
The listed article processing charge (APC) is about US$3,650 for Journal of Drug Issues (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.
What is the quartile of Journal of Drug Issues?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Journal of Drug Issues is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Journal of Drug Issues indexed in Scopus?
Yes. Journal of Drug Issues appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Journal of Drug Issues an SCIE journal?
Journal of Drug Issues is listed in SSCI of the Web of Science Core Collection, but not in SCIE, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Journal of Drug Issues in Journal Citation Reports (JCR)?
Yes. Journal of Drug Issues is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does Journal of Drug Issues offer an APC waiver?
Journal of Drug Issues follows the policy of SAGE: automatic full waiver for Research4Life Group A and a discount for Group B, by the corresponding author's affiliation. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.
Has Journal of Drug Issues retracted papers?
Yes. 1 retracted paper are on record for Journal of Drug Issues, 1 of them in the last 10 years; the most common reasons are concerns/issues about data, error in analyses, error in data. A retraction count alone is not a verdict on a journal; look at the trend and the reasons. Data updated October 2026.
Who funds research published in Journal of Drug Issues?
48% of 109 recent research articles in Journal of Drug Issues name a funder; the funders named most often are National Institute on Drug Abuse, National Institutes of Health, Bureau of Justice Assistance.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Ceramics International
- Thin Solid Films
- Journal of Applied Polymer Science
- RSC Advances
- Journal of Applied Physics
- Journal of Physical Chemistry B
- Chemical Communications
- Biophysical Journal
- Physics Today
- Journal of Bacteriology
- IEEE Access
- Sustainability
- Medical Physics
- Analytica Chimica Acta
Browse all journals: indexing, impact factor and reviewer comments →